Market News & Trends
Teneobio's Next Generation T Cell Redirection Antibody Platform for Cancer Biotherapeutics Offers Prospects of Reducing Cytokine Release
Teneobio, Inc, a next-generation antibody therapeutics company, recently announced the discovery of a large panel of human anti-CD3 binders with diverse affinities and tune-able T-cell…
Teneobio's Next Generation T Cell Redirection Antibody Platform for Cancer Biotherapeutics Offers Prospects of Reducing Cytokine Release
Teneobio, Inc, a next-generation antibody therapeutics company, recently announced the discovery of a large panel of human anti-CD3 binders with diverse affinities and tune-able T-cell…
DiFUSION Technologies Announces Breakthrough SMART Biomaterial Platform
DiFusion recently announced the completion of a series of in vitro tests and in vivo studies, carried out in part at Clemson University and the…
MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups
MilliporeSigma recently announced the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, MA. LabCentral is a private, non-profit organization that…
Metrion Biosciences & Venomtech Announce Research Collaboration
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and Venomtech Limited (Venomtech) a biotechnology company with the UK’s largest venom…
endpoint Enhances & Extends IRT With Latest Technology Innovation
endpoint Clinical, a leading global interactive response technology (IRT) company, recently announced a significant enhancement to its proprietary PULSE platform, reshaping the way IRT is…
Creative & Integrated Pharmaceutical Lifecycle Management Strategies Remain Vital in Tough Market Environment
As the pharmaceutical industry continues to face a variety of challenges, such as pricing pressures, stringent regulatory policies, and declining R&D productivity, it is seeking…
Atara Bio Announces Collaboration With Merck
Atara Biotherapeutics, Inc. recently announced it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the United States and Canada),…
Genisphere Begins Collaborative & Sponsored Research Program With the University of Maryland
Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia…
Pharmatek Adds Further cGMP Spray Drying Capacity in Response to Demand for Improved Pharmaceutical Solubility
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced that it…
Genisphere Begins Collaborative & Sponsored Research Program With the University of Maryland
Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia…
Pharmatek Adds Further cGMP Spray Drying Capacity in Response to Demand for Improved Pharmaceutical Solubility
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced that it…
Q BioMed Announces Licensing Agreement
Q BioMed Inc. (QBIO) and ASDERA LLC recently announced a licensing agreement that provides Q BioMed with the worldwide exclusive rights to ASDERA's ASD-002, which is…
Q BioMed Announces Licensing Agreement
Q BioMed Inc. (QBIO) and ASDERA LLC recently announced a licensing agreement that provides Q BioMed with the worldwide exclusive rights to ASDERA's ASD-002, which is…
GNT Biotech & Medicals Corporation to Begin Phase III Clinical Trial
GNT Biotech & Medicals Co., Ltd. recently announced that the anticancer drug Chidamide (HBI-8000), an epigenetic regulator developed by Chipscreen Biosciences Ltd., of Shenzhen, China,…
Sucampo Publishes Study Results for Treatment of Niemann-Pick Disease Type C1
Sucampo Pharmaceuticals, Inc. recently announced the publication of a new study in an independent scientific journal that confirms the unique composition of VTS-270, a 2-Hydroxypropyl-beta-cyclodextrin…
Protalix BioTherapeutics Announces New Preclinical Results
Protalix BioTherapeutics, Inc. recently announced new, promising results from a preclinical trial conducted in collaboration with Prof. Raphael Schiffmann, Director, Institute of Metabolic Disease at…
Motif Bio Announces Positive Results for Iclaprim, in the REVIVE-1 Phase III Study
Motif Bio plc recently announced positive topline results from REVIVE-1, a global Phase III clinical trial of its investigational drug candidate iclaprim in patients with…
Cobra Biologics Embarks on Gene Therapy Manufacturing Operations Expansion
Cobra Biologics, an international CDMO of biologics and pharmaceuticals, recently announced it is to expand operations at its sites in UK and Sweden to meet…
Cellectar Biosciences Receives Patent for CLR 131 & CLR 125 for the Treatment of Cancer Stem Cells
Cellectar Biosciences, Inc. recently announced the Japanese Patent Office has granted a method of use patent for two of the company’s phospholipid drug conjugates (PDCs),…
